Trials / Completed
CompletedNCT02411461
Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 39 (actual)
- Sponsor
- Vanderbilt University Medical Center · Academic / Other
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Accepted
Summary
Pseudohypoparathyroidism type 1a (PHP1a) is a rare disease that causes childhood obesity and learning difficulties. This study will investigate eating behaviors and perform cognitive testing on children with PHP1a. The investigators will compare their results to those of healthy siblings and other obese children.
Detailed description
Pseudohypoparathyroidism type 1a (PHP1a) is a genetic disorder that causes early-onset, syndromic obesity and cognitive impairment. This study aims to evaluate eating behaviors, cognition and executive function in children with PHP1a, compared with healthy siblings and matched obese controls.
Conditions
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2015-04-08
- Last updated
- 2019-11-13
- Results posted
- 2018-06-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02411461. Inclusion in this directory is not an endorsement.